Autopsy report · NCT02737930

Fluoxetine for Visual Recovery After Ischemic Stroke

“Slow recruitment and lack of funding to expand to other sites.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 4 years 3 months before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Bogachan Sahin

Sponsor type

University, hospital or other

Conditions

Acute Stroke; Visual Field Loss

Interventions

Fluoxetine; Placebo

Participants

17

Sites

1

Countries

United States

Trials that died the same way

• Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
  “Slow recruitment and inability to extend funding.” (75% match in meaning)
• Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?
  “lack of recruitment at this site” (75% match in meaning)
• Functional Electrical Stimulation (FES) Exercise Training in Hemodialysis Patients
  “Lack of recruitment” (74% match in meaning)
• Reach Out and Read Arabic to Promote Arabic Literacy in Toddlers
  “Poor recruitment and lack of funding” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.